FDA Panel Will Weigh Benefits, Risks Of Pfizer's COVID-19 Vaccine

A federal advisory committee is evaluating Pfizer's COVID-19 vaccine. The Food and Drug Administration will weigh that input as it decides whether to grant emergency use for the vaccine.

[Copyright 2020 NPR]